Cold Spring Harbor Laboratory
Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target
Publication
, Preprint
Peacock, JD; Pridgeon, MG; Tovar, EA; Essenburg, CJ; Bowman, M; Madaj, Z; Koeman, J; Grit, J; Dodd, RD; Cardona, DM; Chen, M; Kirsch, DG ...
October 5, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Peacock, J. D., Pridgeon, M. G., Tovar, E. A., Essenburg, C. J., Bowman, M., Madaj, Z., … Steensma, M. R. (2017). Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target. Cold Spring Harbor Laboratory. https://doi.org/10.1101/199000
Peacock, Jacqueline D., Matthew G. Pridgeon, Elizabeth A. Tovar, Curt J. Essenburg, Megan Bowman, Zachary Madaj, Julie Koeman, et al. “Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target.” Cold Spring Harbor Laboratory, October 5, 2017. https://doi.org/10.1101/199000.
Peacock JD, Pridgeon MG, Tovar EA, Essenburg CJ, Bowman M, Madaj Z, et al. Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target. Cold Spring Harbor Laboratory. 2017.
Peacock, Jacqueline D., et al. “Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target.” Cold Spring Harbor Laboratory, 5 Oct. 2017. Crossref, doi:10.1101/199000.
Peacock JD, Pridgeon MG, Tovar EA, Essenburg CJ, Bowman M, Madaj Z, Koeman J, Grit J, Dodd RD, Cardona DM, Chen M, Kirsch DG, Maina F, Dono R, Winn ME, Graveel CR, Steensma MR. Genomic MET amplification occurs early in NF1-related malignant peripheral nerve sheath tumor (MPNST) progression and is a potent therapeutic target. Cold Spring Harbor Laboratory. 2017.